0001213900-23-096082.txt : 20231215
0001213900-23-096082.hdr.sgml : 20231215
20231215160825
ACCESSION NUMBER: 0001213900-23-096082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING THOMAS BRAXTON
CENTRAL INDEX KEY: 0001279309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 231490365
MAIL ADDRESS:
STREET 1: 91 JAMES AVENUE
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0508
4
2023-12-13
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001279309
KING THOMAS BRAXTON
91 JAMES AVENUE
ATHERTON
CA
94027
1
0
0
0
0
Stock Options (Right to Buy)
0.35
2023-12-13
4
A
0
132442
0
A
2024-12-13
2033-12-13
Common Stock
132442
132442
D
The options vest and first become exercisable in 36 equal monthly installments, with the first installment vesting on December 13, 2024 and the remaining installments on the 13th of the month for the next 35 months.
/s/ Thomas B. King
2023-12-15